These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21970310)

  • 1. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic investigation of digoxin in Japanese infants and young children.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
    Choi SA; Yun HY; Lee ES; Shin WG
    Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
    Araki R; Yukawa E; Nakashima MN; Fukuchi H; Sasaki H; Yano K; Nakashima M
    Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Mine H; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of digoxin in elderly patients.
    Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL
    Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.
    Williams PJ; Lane J; Murray W; Mergener MA; Kamigaki M
    Clin Pharmacokinet; 1992 Jan; 22(1):66-74. PubMed ID: 1559308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Hokazono T; Yukawa M; Ichimaru R; Maki T; Matsunaga K; Ohdo S; Anai M; Higuchi S; Goto Y
    Clin Pharmacokinet; 2002; 41(2):153-9. PubMed ID: 11888334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice.
    Zhou XD; Gao Y; Guan Z; Li ZD; Li J
    Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen.
    Salcedo-Mingoarranz AL; Medellín-Garibay SE; Barcia-Hernández E; García-Díaz B
    Clin Pharmacokinet; 2023 Dec; 62(12):1725-1738. PubMed ID: 37816957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants.
    Gong Y; Chen Y; Li Q; Li Z
    J Pharmacol Sci; 2014; 125(2):142-9. PubMed ID: 24837877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data.
    Hirai T; Kasai H; Naganuma M; Hagiwara N; Shiga T
    BMC Pharmacol Toxicol; 2022 Feb; 23(1):14. PubMed ID: 35144695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.